Maintenance of Th1 hepatitis C virus (HCV)‐specific responses in individuals with acute HCV who achieve sustained virological clearance after treatment
暂无分享,去创建一个
J. Kaldor | M. Hellard | G. Dore | J. Flynn | P. White | A. Lloyd | W. Rawlinson | R. Ffrench | B. Yeung | Jacqueline K. Flynn
[1] J. Kaldor,et al. Impaired hepatitis C virus (HCV)-specific interferon-γ responses in individuals with HIV who acquire HCV infection: correlation with CD4(+) T-cell counts. , 2012, The Journal of infectious diseases.
[2] Todd M. Allen,et al. Broadly directed virus-specific CD4+ T cell responses are primed during acute hepatitis C infection, but rapidly disappear from human blood with viral persistence , 2012, The Journal of experimental medicine.
[3] J. Kaldor,et al. Early IL‐10 predominant responses are associated with progression to chronic hepatitis C virus infection in injecting drug users , 2011, Journal of viral hepatitis.
[4] M. Alavi,et al. Adherence to treatment for recently acquired hepatitis C virus (HCV) infection among injecting drug users. , 2011, Journal of hepatology.
[5] T. Liang,et al. Sporadic reappearance of minute amounts of hepatitis C virus RNA after successful therapy stimulates cellular immune responses. , 2011, Gastroenterology.
[6] J. Kaldor,et al. Potential role for Interleukin‐28B genotype in treatment decision‐making in recent hepatitis C virus infection , 2010, Hepatology.
[7] M. Ostrowski,et al. Comparison of Immune Restoration in Early versus Late Alpha Interferon Therapy against Hepatitis C Virus , 2010, Journal of Virology.
[8] J. Kaldor,et al. Effective treatment of injecting drug users with recently acquired hepatitis C virus infection. , 2010, Gastroenterology.
[9] R. Chung,et al. Rate of sustained virologic response in relation to baseline hepatitis C virus (HCV) RNA level and rapid virologic clearance in persons with acute HCV infection. , 2009, The Journal of infectious diseases.
[10] G. Freeman,et al. Impaired Hepatitis C Virus (HCV)-Specific Effector CD8+ T Cells Undergo Massive Apoptosis in the Peripheral Blood during Acute HCV Infection and in the Liver during the Chronic Phase of Infection , 2008, Journal of Virology.
[11] J. Villeneuve,et al. Early Interferon Therapy for Hepatitis C Virus Infection Rescues Polyfunctional, Long-Lived CD8+ Memory T Cells , 2008, Journal of Virology.
[12] Kyong‐Mi Chang,et al. Peripheral virus-specific T-cell interleukin-10 responses develop early in acute hepatitis C infection and become dominant in chronic hepatitis. , 2008, Journal of hepatology.
[13] E. Riley,et al. IL-10: The Master Regulator of Immunity to Infection , 2008, The Journal of Immunology.
[14] B. Palmer,et al. Upregulation of PD-1 Expression on Circulating and Intrahepatic Hepatitis C Virus-Specific CD8+ T Cells Associated with Reversible Immune Dysfunction , 2007, Journal of Virology.
[15] E. Wherry,et al. IL-10, T cell exhaustion and viral persistence. , 2007, Trends in microbiology.
[16] M. Manns,et al. Fate and Function of Hepatitis-C-Virus-Specific T-Cells during Peginterferon-α2b therapy for Acute Hepatitis C , 2006, Antiviral therapy.
[17] G. Freeman,et al. Liver-Infiltrating Lymphocytes in Chronic Human Hepatitis C Virus Infection Display an Exhausted Phenotype with High Levels of PD-1 and Low Levels of CD127 Expression , 2006, Journal of Virology.
[18] H. Pircher,et al. Analysis of CD127 and KLRG1 Expression on Hepatitis C Virus-Specific CD8+ T Cells Reveals the Existence of Different Memory T-Cell Subsets in the Peripheral Blood and Liver , 2006, Journal of Virology.
[19] J. Klarquist,et al. Loss of IL‐7 receptor alpha‐chain (CD127) expression in acute HCV infection associated with viral persistence , 2006, Hepatology.
[20] L. Teyton,et al. Interleukin-10 determines viral clearance or persistence in vivo , 2006, Nature Medicine.
[21] M. Massari,et al. PD-1 Expression in Acute Hepatitis C Virus (HCV) Infection Is Associated with HCV-Specific CD8 Exhaustion , 2006, Journal of Virology.
[22] William M. Lee,et al. HCV RNA detection by TMA during the hepatitis C antiviral long‐term treatment against cirrhosis (Halt‐C) trial , 2006, Hepatology.
[23] N. Afdhal,et al. Peginterferon alfa-2b therapy in acute hepatitis C: impact of onset of therapy on sustained virologic response. , 2006, Gastroenterology.
[24] Bin Li,et al. Full-Breadth Analysis of CD8+ T-Cell Responses in Acute Hepatitis C Virus Infection and Early Therapy , 2005, Journal of Virology.
[25] F. Negro,et al. Barriers to interferon-α therapy are higher in intravenous drug users than in other patients with acute hepatitis C , 2005 .
[26] T. Santantonio,et al. Efficacy of a 24-week course of PEG-interferon alpha-2b monotherapy in patients with acute hepatitis C after failure of spontaneous clearance. , 2005, Journal of hepatology.
[27] F. Chisari,et al. T cell response in hepatitis C virus infection. , 2005, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[28] Salim I. Khakoo,et al. HLA and NK Cell Inhibitory Receptor Genes in Resolving Hepatitis C Virus Infection , 2004, Science.
[29] J. Hoofnagle,et al. Effects of antiviral therapy on the cellular immune response in acute hepatitis C , 2004, Hepatology.
[30] M. Manns,et al. Long‐term follow‐up after successful interferon therapy of acute hepatitis C , 2004, Hepatology.
[31] C. Graham,et al. Pegylated interferon α therapy in acute hepatitis C: Relation to hepatitis C virus–specific T cell response kinetics , 2004, Hepatology.
[32] E. Wherry,et al. Memory CD8 T-Cell Differentiation during Viral Infection , 2004, Journal of Virology.
[33] D. Accapezzato,et al. Subversion of effector CD8+ T cell differentiation in acute hepatitis C virus infection: exploring the immunological mechanisms , 2004, European journal of immunology.
[34] N. Gruener,et al. Acute hepatitis C: high rate of both spontaneous and treatment-induced viral clearance. , 2003, Gastroenterology.
[35] M. Manns,et al. 250 24 weeks of monotherapy with pegylated interferon alfa-2B in patients with acute hepatitis C , 2003 .
[36] J. Hoofnagle,et al. Impaired Effector Function of Hepatitis C Virus-Specific CD8+ T Cells in Chronic Hepatitis C Virus Infection1 , 2002, The Journal of Immunology.
[37] A. Ursitti,et al. Association of circulating CD8(+) lymphocytes to a spontaneous and interferon-alpha induced clearance of HCV. , 2002, Hepatology research : the official journal of the Japan Society of Hepatology.
[38] W. Rosenberg,et al. Quantitative and functional differences in CD8+ lymphocyte responses in resolved acute and chronic hepatitis C virus infection , 2002, Journal of viral hepatitis.
[39] F. Chisari,et al. Determinants of Viral Clearance and Persistence during Acute Hepatitis C Virus Infection , 2001, The Journal of experimental medicine.
[40] F. Chisari,et al. Noncytolytic control of viral infections by the innate and adaptive immune response. , 2001, Annual review of immunology.
[41] R. Coffman,et al. Interleukin-10 and the interleukin-10 receptor. , 2001, Annual review of immunology.
[42] P. Klenerman,et al. CD8+ T lymphocyte responses are induced during acute hepatitis C virus infection but are not sustained , 2000, European journal of immunology.
[43] S. Opal,et al. The role of interleukin-10 in critical illness. , 2000, Current opinion in infectious diseases.
[44] M. Cucchiarini,et al. Association of hepatitis C virus-specific CD8+ T cells with viral clearance in acute hepatitis C. , 2000, The Journal of infectious diseases.
[45] B. Walker,et al. Analysis of Successful Immune Responses in Persons Infected with Hepatitis C Virus , 2000, The Journal of experimental medicine.
[46] T. Santantonio,et al. Recurrence of hepatitis C virus after loss of virus-specific CD4(+) T-cell response in acute hepatitis C. , 1999, Gastroenterology.
[47] M. Houghton,et al. Recurrence of hepatitis C virus after loss of virus specific CD4+ T cell response in acute hepatitis C , 1998 .
[48] V. Barnaba,et al. Normalization of depressed natural killer activity after interferon-alpha therapy is associated with a low frequency of relapse in patients with chronic hepatitis C. , 1993, International journal of tissue reactions.